UnitedHealth Group (UNH) Stock Forecast, Price Target & Predictions
UNH Stock Forecast
UnitedHealth Group stock forecast is as follows: an average price target of $569.20 (represents a -4.23% downside from UNH’s last price of $594.32) and a rating consensus of 'Buy', based on 28 wall street analysts offering a 1-year stock forecast.
UNH Price Target
UNH Analyst Ratings
UnitedHealth Group Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Jul 17, 2024 | David Toung | Argus Research | $600.00 | $565.78 | 6.05% | 0.96% |
Jul 17, 2024 | David MacDonald | Truist Financial | $640.00 | $548.87 | 16.60% | 7.69% |
Jul 17, 2024 | Scott Fidel | Stephens | $600.00 | $548.87 | 9.32% | 0.96% |
Jul 17, 2024 | David Windley | Jefferies | $647.00 | $573.28 | 12.86% | 8.86% |
Jun 05, 2024 | Sidharth Sahoo | HSBC | $580.00 | $503.12 | 15.28% | -2.41% |
Apr 19, 2024 | George Hill | Deutsche Bank | $562.00 | $493.18 | 13.95% | -5.44% |
Apr 17, 2024 | Stephen Baxter | Wells Fargo | $525.00 | $483.15 | 8.66% | -11.66% |
Apr 17, 2024 | Ben Hendrix | RBC Capital | $555.00 | $468.89 | 18.36% | -6.62% |
Apr 17, 2024 | Jessica Tassan | Piper Sandler | $571.00 | $468.89 | 21.78% | -3.92% |
Apr 11, 2024 | Jessica Tassan | Piper Sandler | $566.00 | $450.05 | 25.76% | -4.77% |
UnitedHealth Group Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | 4 | 12 |
Avg Price Target | - | $621.75 | $574.17 |
Last Closing Price | $594.32 | $594.32 | $594.32 |
Upside/Downside | -100.00% | 4.62% | -3.39% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Sep 10, 2024 | Wells Fargo | Buy | Buy | Hold |
Sep 10, 2024 | UBS | Underperform | Underperform | Hold |
Aug 19, 2024 | Wells Fargo | Buy | Buy | Hold |
Jul 17, 2024 | Wells Fargo | Buy | Buy | Hold |
Jul 17, 2024 | RBC Capital | Underperform | Underperform | Hold |
Jul 17, 2024 | RBC Capital | Outperform | Outperform | Hold |
Jul 17, 2024 | Cowen & Co. | Buy | Buy | Hold |
Jul 17, 2024 | Morgan Stanley | Overweight | Overweight | Hold |
Jul 17, 2024 | Wells Fargo | Overweight | Overweight | Hold |
Jul 17, 2024 | Stephens | Overweight | Overweight | Hold |
UnitedHealth Group Financial Forecast
UnitedHealth Group Revenue Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | $92.36B | $91.79B | $91.13B | $81.93B | $80.38B | - | $79.78B | $72.93B | $71.83B | $70.77B | $69.74B | $65.02B | $64.76B | $61.80B | $64.06B | $60.47B | $59.88B |
Avg Forecast | $116.81B | $114.14B | $114.47B | $113.53B | $109.32B | $107.35B | $107.33B | $106.61B | $100.91B | $99.15B | $98.79B | $99.23B | $92.13B | $91.41B | $90.97B | $89.71B | $82.48B | $80.52B | $79.68B | $78.73B | $72.98B | $71.38B | $69.51B | $69.07B | $64.96B | $63.79B | $63.48B | $64.16B | $60.96B | $59.76B |
High Forecast | $118.67B | $115.95B | $116.29B | $115.33B | $111.06B | $109.06B | $109.04B | $108.31B | $102.52B | $100.31B | $100.36B | $100.81B | $93.44B | $92.87B | $92.42B | $91.14B | $83.80B | $81.80B | $79.68B | $79.57B | $73.77B | $72.15B | $70.25B | $69.81B | $65.66B | $64.47B | $64.16B | $64.85B | $61.61B | $60.40B |
Low Forecast | $115.71B | $113.06B | $113.38B | $112.45B | $108.29B | $106.33B | $106.32B | $105.61B | $99.96B | $97.74B | $97.85B | $98.30B | $90.78B | $90.55B | $90.11B | $88.86B | $81.70B | $79.76B | $79.68B | $77.47B | $71.81B | $70.24B | $68.39B | $67.97B | $63.92B | $62.77B | $62.47B | $63.14B | $59.98B | $58.81B |
# Analysts | 6 | 6 | 12 | 11 | 10 | 9 | 8 | 7 | 8 | 13 | 6 | 6 | 12 | 9 | 9 | 9 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 6 | 11 | 10 | 10 | 11 | 6 | 5 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.01% | 1.01% | 1.02% | 0.99% | 1.00% | - | 1.01% | 1.00% | 1.01% | 1.02% | 1.01% | 1.00% | 1.02% | 0.97% | 1.00% | 0.99% | 1.00% |
UnitedHealth Group EBITDA Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 6 | 6 | 12 | 11 | 10 | 9 | 8 | 7 | 8 | 13 | 6 | 6 | 12 | 9 | 9 | 9 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 6 | 11 | 10 | 10 | 11 | 6 | 5 |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | $9.53B | $7.96B | $8.26B | $7.02B | $7.78B | - | $7.37B | $6.19B | $6.40B | $6.65B | $7.38B | $4.11B | $5.29B | $9.90B | $5.64B | $5.69B | $5.63B |
Avg Forecast | $10.57B | $10.33B | $10.36B | $10.28B | $9.90B | $9.72B | $9.72B | $9.65B | $9.13B | $8.97B | $8.94B | $9.03B | $8.34B | $8.27B | $8.23B | $8.21B | $7.47B | $6.87B | $7.26B | $7.46B | $5.93B | $6.24B | $6.21B | $5.81B | $3.92B | $4.57B | $6.45B | $5.50B | $5.49B | $5.44B |
High Forecast | $10.74B | $10.50B | $10.53B | $10.44B | $10.05B | $9.87B | $9.87B | $9.80B | $9.28B | $9.08B | $9.08B | $10.83B | $8.46B | $8.41B | $8.37B | $9.85B | $7.59B | $8.24B | $7.26B | $8.95B | $7.12B | $7.49B | $7.46B | $6.98B | $4.71B | $5.48B | $7.74B | $6.60B | $6.59B | $6.52B |
Low Forecast | $10.47B | $10.23B | $10.26B | $10.18B | $9.80B | $9.63B | $9.62B | $9.56B | $9.05B | $8.85B | $8.86B | $7.22B | $8.22B | $8.20B | $8.16B | $6.57B | $7.40B | $5.49B | $7.26B | $5.97B | $4.75B | $4.99B | $4.97B | $4.65B | $3.14B | $3.65B | $5.16B | $4.40B | $4.39B | $4.35B |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.15% | 0.97% | 1.01% | 0.94% | 1.13% | - | 0.99% | 1.04% | 1.03% | 1.07% | 1.27% | 1.05% | 1.16% | 1.53% | 1.03% | 1.04% | 1.04% |
UnitedHealth Group Net Income Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 6 | 6 | 12 | 11 | 10 | 9 | 8 | 7 | 8 | 13 | 6 | 6 | 12 | 9 | 9 | 9 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 6 | 11 | 10 | 10 | 11 | 6 | 5 |
Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | $5.84B | $5.47B | $5.61B | $4.76B | $5.26B | - | $5.03B | $4.19B | $4.09B | $4.27B | $4.86B | $2.21B | $3.17B | $6.64B | $3.38B | $3.54B | $3.54B |
Avg Forecast | $8.10B | $8.47B | $8.02B | $8.04B | $7.25B | $7.50B | $7.11B | $7.04B | $6.41B | $6.55B | $6.17B | $5.96B | $5.55B | $5.88B | $5.56B | $5.42B | $4.80B | $4.38B | $4.80B | $4.92B | $3.90B | $3.98B | $3.99B | $3.83B | $2.11B | $2.74B | $4.32B | $3.30B | $3.42B | $3.42B |
High Forecast | $8.26B | $8.64B | $8.18B | $8.21B | $7.40B | $7.65B | $7.26B | $7.18B | $6.54B | $6.73B | $6.30B | $7.15B | $5.59B | $6.00B | $5.67B | $6.50B | $4.90B | $5.26B | $4.80B | $5.91B | $4.68B | $4.78B | $4.78B | $4.60B | $2.53B | $3.29B | $5.19B | $3.96B | $4.10B | $4.10B |
Low Forecast | $8.00B | $8.36B | $7.92B | $7.94B | $7.16B | $7.40B | $7.02B | $6.95B | $6.33B | $6.39B | $6.09B | $4.77B | $5.48B | $5.81B | $5.49B | $4.33B | $4.74B | $3.51B | $4.80B | $3.94B | $3.12B | $3.19B | $3.19B | $3.06B | $1.69B | $2.19B | $3.46B | $2.64B | $2.74B | $2.73B |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.99% | 0.98% | 1.04% | 0.99% | 1.20% | - | 1.02% | 1.07% | 1.03% | 1.07% | 1.27% | 1.05% | 1.16% | 1.53% | 1.03% | 1.04% | 1.04% |
UnitedHealth Group SG&A Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 6 | 6 | 12 | 11 | 10 | 9 | 8 | 7 | 8 | 13 | 6 | 6 | 12 | 9 | 9 | 9 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 6 | 11 | 10 | 10 | 11 | 6 | 5 |
SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Avg Forecast | $17.63B | $17.23B | $17.28B | $17.14B | $16.50B | $16.20B | $16.20B | $16.09B | $15.23B | $14.96B | $14.91B | $14.98B | $13.91B | $13.80B | $13.73B | $13.54B | $12.45B | $12.15B | $12.02B | $9.56B | $8.86B | $8.67B | $8.44B | $8.39B | $7.89B | $7.75B | $7.71B | $7.79B | $7.40B | $7.26B |
High Forecast | $17.91B | $17.50B | $17.55B | $17.41B | $16.76B | $16.46B | $16.46B | $16.35B | $15.47B | $15.14B | $15.15B | $15.22B | $14.10B | $14.02B | $13.95B | $13.76B | $12.65B | $12.35B | $12.02B | $9.66B | $8.96B | $8.76B | $8.53B | $8.48B | $7.97B | $7.83B | $7.79B | $7.88B | $7.48B | $7.34B |
Low Forecast | $17.47B | $17.06B | $17.11B | $16.97B | $16.35B | $16.05B | $16.05B | $15.94B | $15.09B | $14.75B | $14.77B | $14.84B | $13.70B | $13.67B | $13.60B | $13.41B | $12.33B | $12.04B | $12.02B | $9.41B | $8.72B | $8.53B | $8.31B | $8.25B | $7.76B | $7.62B | $7.59B | $7.67B | $7.28B | $7.14B |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
UnitedHealth Group EPS Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 6 | 6 | 12 | 11 | 10 | 9 | 8 | 7 | 8 | 13 | 6 | 6 | 12 | 9 | 9 | 9 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 6 | 11 | 10 | 10 | 11 | 6 | 5 |
EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | $6.31 | $5.88 | $6.01 | $5.10 | $5.63 | - | $5.34 | $4.45 | $4.34 | $4.52 | $5.15 | $2.34 | $3.34 | $6.99 | $3.57 | $3.74 | $3.74 |
Avg Forecast | $8.72 | $9.12 | $8.64 | $8.66 | $7.81 | $8.08 | $7.66 | $7.58 | $6.91 | $7.06 | $6.65 | $6.61 | $5.98 | $6.33 | $5.99 | $6.16 | $5.17 | $5.43 | $5.21 | $5.37 | $4.31 | $4.42 | $4.43 | $4.39 | $2.41 | $3.11 | $5.28 | $3.63 | $3.78 | $3.75 |
High Forecast | $8.90 | $9.31 | $8.82 | $8.84 | $7.97 | $8.25 | $7.82 | $7.74 | $7.05 | $7.26 | $6.79 | $6.75 | $6.02 | $6.47 | $6.11 | $6.29 | $5.28 | $5.54 | $5.21 | $5.45 | $4.37 | $4.48 | $4.49 | $4.45 | $2.44 | $3.15 | $5.35 | $3.68 | $3.83 | $3.80 |
Low Forecast | $8.62 | $9.01 | $8.53 | $8.56 | $7.72 | $7.98 | $7.57 | $7.49 | $6.82 | $6.89 | $6.57 | $6.53 | $5.90 | $6.26 | $5.92 | $6.09 | $5.11 | $5.36 | $5.21 | $5.26 | $4.22 | $4.32 | $4.34 | $4.30 | $2.36 | $3.04 | $5.17 | $3.55 | $3.70 | $3.67 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.00% | 0.98% | 0.98% | 0.99% | 1.04% | - | 0.99% | 1.03% | 0.98% | 1.02% | 1.17% | 0.97% | 1.08% | 1.32% | 0.98% | 0.99% | 1.00% |
UnitedHealth Group Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
CVS | CVS Health | $57.98 | $103.77 | 78.98% | Hold |
HUM | Humana | $321.56 | $500.84 | 55.75% | Hold |
CNC | Centene | $75.35 | $92.60 | 22.89% | Buy |
ELV | Elevance Health | $550.84 | $556.91 | 1.10% | Buy |
MOH | Molina Healthcare | $358.20 | $358.63 | 0.12% | Hold |
UNH | UnitedHealth Group | $594.32 | $569.20 | -4.23% | Buy |
CI | Cigna | $364.72 | $318.74 | -12.61% | Buy |
ALHC | Alignment Healthcare | $11.89 | $9.50 | -20.10% | Buy |
UNH Forecast FAQ
Is UnitedHealth Group a good buy?
Yes, according to 28 Wall Street analysts, UnitedHealth Group (UNH) is considered a 'Buy'. The rating consensus is based on 1 'Strong Buy' and 23 'Buy' recommendations, accounting for 85.71% of UNH's total ratings.
What is UNH's price target?
UnitedHealth Group (UNH) average price target is $569.2 with a range of $442 to $647, implying a -4.23% from its last price of $594.32. The data is based on 28 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will UnitedHealth Group stock go up soon?
According to Wall Street analysts' prediction for UNH stock, the company can go down by -4.23% (from the last price of $594.32 to the average price target of $569.2), up by 8.86% based on the highest stock price target, and down by -25.63% based on the lowest stock price target.
Can UnitedHealth Group stock reach $900?
UNH's average twelve months analyst stock price target of $569.2 does not support the claim that UnitedHealth Group can reach $900 in the near future.
What are UnitedHealth Group's analysts' financial forecasts?
UnitedHealth Group's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $430.62B (high $437.47B, low $426.55B), average EBITDA is $38.98B (high $39.6B, low $38.61B), average net income is $28.9B (high $29.49B, low $28.54B), average SG&A $65B (high $66.03B, low $64.38B), and average EPS is $31.14 (high $31.78, low $30.76). UNH's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $458.94B (high $466.25B, low $454.61B), average EBITDA is $41.54B (high $42.2B, low $41.15B), average net income is $32.62B (high $33.3B, low $32.22B), average SG&A $69.27B (high $70.37B, low $68.62B), and average EPS is $35.15 (high $35.88, low $34.72).
Did the UNH's actual financial results beat the analysts' financial forecasts?
Based on UnitedHealth Group's last annual report (Dec 2022), the company's revenue was $322.13B, beating the average analysts forecast of $321.41B by 0.22%. Apple's EBITDA was $29.8B, beating the average prediction of $29.05B by 2.58%. The company's net income was $20.12B, beating the average estimation of $18.91B by 6.42%. Apple's SG&A was $0, missing the average forecast of $46.18B by -100.00%. Lastly, the company's EPS was $21.47, beating the average prediction of $21.18 by 1.37%. In terms of the last quarterly report (Sep 2023), UnitedHealth Group's revenue was $92.36B, beating the average analysts' forecast of $91.41B by 1.04%. The company's EBITDA was $9.53B, beating the average prediction of $8.27B by 15.20%. UnitedHealth Group's net income was $5.84B, missing the average estimation of $5.88B by -0.63%. The company's SG&A was $0, missing the average forecast of $13.8B by -100.00%. Lastly, the company's EPS was $6.31, missing the average prediction of $6.33 by -0.38%